对68Ga-DOTATATE和18F-DOPA PET扫描用于检测导致异位ACTH综合征的瘤的前性评估

Henrik Elenius1, Raven McGlotten1, Chuong D Hoang2

  • 1Diabetes and Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.

概括

-68DOTATATE (DOTA) 和18F-DOPA (DOPA) PET/CT扫描显著改善了异位ACTH综合征 (EAS) 中的瘤检测. 这些功能成像技术是互补的,增强了传统扫描对EAS诊断的灵敏度和积极预测价值.